Skip to main content

Search Results

Matthew

Matthew

Our Matthew was first diagnosed with acute lymphoblastic leukemia (ALL) in August 2015 at the age of 12. He relapsed with ALL in December 2016 and underwent his first bone marrow transplant in February 2017 with marrow from an anonymous male donor from New Jersey.

In January 2019, he was diagnosed with mixed phenotype acute leukemia (MPAL). He underwent his second bone marrow transplant in February 2019 with marrow from his first donor's twin brother. Our two families have become very close since we were able to meet after the first transplant.

acute myeloid leukemia (AML)

David

My beloved husband, David served the community of Arlington, Texas, through the fire department for 38 years. Throughout his career, he served the city and trained and mentored other up-and-coming firefighters. He retired in 2017, and just nine months later, he was diagnosed with acute myeloid leukemia (AML), a very aggressive blood cancer. His oncologists believe it had simmered in David's marrow for a couple of years before it went acute. It came on with similar symptoms to the common flu. 

acute myeloid leukemia (AML)

Madeline

I was diagnosed with acute myeloid leukemia (AML) in June of 2022. I was feeling fine and went for a routine physical where it was discovered that my white blood cell count was very low. This was the beginning of my nightmare. I was slotted to give my husband my kidney before I was diagnosed and had to quickly find another donor. We did and he got his transplant and is doing well. I was hospitalized for 8 weeks where I received very aggressive induction chemo that left me malnourished and on death’s doorstep.

bone marrow saves lives

Liz

I've been affiliated with The Leukemia & Lymphoma Society (LLS) for many years through the volunteer/fundraising opportunities available to my kids. Little did I know I'd be visiting your website for my own needs once my mom was diagnosed with acute myeloid leukemia (AML) in January 2023. I'm overwhelmed with the advances made by LLS and find your organization to be a tremendous resource filled with hope. I always click on your stories and decide I want to share mine because I feel like my story and that of my mom's offers just that, HOPE!

When Your Child Has Cancer

Hearing that your child has cancer is terrifying for any parent. Today, most childhood cancer patients can expect to have full and productive lives. Many childhood cancer survivors return to school, attend college, enter the workforce, marry and become parents. Nevertheless, being vigilant about follow-up care, being aware of long-term and late effects of treatment, helping your child return to school and even dealing with your emotions are all things you’ll need to manage.  

Radiation Therapy

Radiation therapy uses X-rays or other high-energy rays to kill cancer cells. Radiation therapy is sometimes used to treat a person with CLL who has an enlarged (swollen) lymph node, spleen, or other organ that is blocking the function of a neighboring body part, such as the kidney or the throat. 

Relapsed and Refractory

Some patients' cancer returns after a successful course of treatment. This is called a relapse.

Some patients' cancer does not respond to treatment. This is called refractory chronic myelomonocytic leukemia (CMML).

If you have relapsed or refractory CMML, talk with your doctor about whether taking part in a clinical trial may be a good option for you.

Dan Klotz

Dan

When cancer hangs your cleats up for good

At my first appointment, the physical therapist asked me why. Why did I want to run a marathon? And I didn't have an answer, partly because when you meet someone, you don't want to blurt out all sorts of emotional baggage, and that's the sort of question that can trigger a lot of baggage.

Other Disease Studies

Another type of study that blood cancer patients and their relatives can participate in is a nontherapeutic study. Nontherapeutic studies aren't considered clinical trials because they don't involve the study of new diagnostics or treatments for diseases. Instead, they're developed to gain a better understanding of disease-incidence patterns or the consequences of specific treatments for a specific disease.

In all cases, you should be asked to sign a consent form that defines the study's purpose and what's expected from the participants.

Melinda

Melinda

I am currently 30 years old and was diagnosed with non-Hodgkin lymphoma (PMBCL) when I was 27, almost 28 years old.

I was pregnant the day I was diagnosed, luckily 39 weeks, and ended up giving birth the same day I found out I had a massive tumor in my mediastinum. I was biopsied the next day and had to leave my 5-day-old baby and 2-year-old to go to the emergency room for a life-threatening emergency called svc syndrome.

AP

Amanda

My name is Amanda, and I am a stage 4b classical multicellularity Hodgkin lymphoma (CHL) survivor. It all started after spring break of my junior year of high school. I was on a ski trip when I noticed my feet were more itchy than normal. I figured it was from the boots. After coming home and realizing it had gotten worse, we went to the pediatrician. She looked at the bruises and scratch marks on my legs and diagnosed me with scabies. I did the whole treatment for that, and obviously, it didn’t work. A week or two later. we went back and had some basic bloodwork done.

Halley

Halley

My story with cancer began long before I was diagnosed this year at 33. When I was 4 years old, my 18-month-old sister, Hannah, became too tired to play with me. As a child, I didn’t know what was going on, but something seemed wrong. My mom started taking her to doctor after doctor to find out what was happening. It wasn’t until we visited my grandmother in Florida that she had to go to the ER, and our family got the concerning news that she may have cancer.

Heriberto

Heriberto

I was diagnosed with Burkitt lymphoma (BL) on Friday the 13th ― August 13, 2021, to be exact ― seven months after being married, three months after my wedding reception, and going on my honeymoon.

Ron

Ron

This started 11 years ago when my mom was first diagnosed with lymphoma. I wanted to do more and saw the purple team always out running events I was entered into. I wanted to join and did in 2010. I have run in countless events over the years with Team In Training (TNT). Then my mom passed in May of 2017 while I was training for the Walt Disney World event. I was crushed and continued to run in her honor. My mom was supposed to be at the finish line at my 2018 Walt Disney World Marathon Weekend, and it did not happen.

young woman with long brown hair wearing hosptial gown puckering her mouth and giving a peace sign lying in a hospital bed

Carly

November 25, 2022 ― the worst day of my life, the day I received my official cancer diagnosis, stage IV Hodgkin lymphoma (HL).

Leading up to this day, I was always a healthy, active young lady. I was 23 years old and eager to start this next phase in life. Exciting things were happening. We were fairly new homeowners, I had just changed jobs/occupations, and I married the love of my life in October.

primary mediastinal non-Hodgkin lymphoma (PMBL)

Kaitlin

I moved to Chicago in May 2022. I had recently finished my joint PhD in Social Work and Psychology from the University of Michigan and was offered a job as a People Analytics Researcher at Google. I loved the city and enjoyed frequent runs and cycling rides along Lake Shore Drive. In mid-July, I started noticing some symptoms that concerned me ― difficulty breathing when I was exercising, intense chest and back pain, spider veins on my chest, puffiness in my face, and fatigue.

Treatment Outcomes

A few decades ago, there were very low cure rates in both children and adults diagnosed with ALL. Today, childhood ALL has one of the highest cure rates of all childhood cancers, approaching 92 percent for children younger than 15 years and more than 94 percent for children younger than 5 years.

Follow-Up Care

Find more information about follow-up care, including what to expect, long-term and late effects of treatment, survivorship clinics, and other resources, such as The National Comprehensive Cancer Network (NCCN) treatment guidelines.

Treatment Outcomes

In some people with PV, the disease remains stable for many years. In many people, life expectancy is the same as it would be if they did not have PV. With careful medical supervision and therapy, PV can usually be managed effectively for a long time. In some cases, however, it may progress to another type of blood disease, such as myelofibrosis or acute myeloid leukemia.

Splenectomy

The spleen is an organ on the left side of the body, near the stomach. CLL cells can collect in the spleen, causing it to become enlarged. Sometimes, the spleen becomes so large that it presses on nearby organs, causing pain. Also, an enlarged spleen may lower a person’s blood cell counts to dangerous levels. An operation to remove the spleen is called a splenectomy. Splenectomy is helpful for select patients. The operation may reduce pain and help improve blood counts. 

Follow-Up Care

Click here for information about follow-up care, including what to expect, long-term and late effects of treatment, survivorship clinics, and other resources such as The National Comprehensive Cancer Network (NCCN) treatment guidelines.

 Use the Survivorship Workbook to collect all the important information you need throughout diagnosis, treatment, follow-up care and long-term management of a blood cancer.

Follow-Up Care

Click here for information about follow-up care, including what to expect, long-term and late effects of treatment, survivorship clinics, and other resources such as The National Comprehensive Cancer Network (NCCN) treatment guidelines.

 Use the Survivorship Workbook to collect all the important information you need throughout diagnosis, treatment, follow-up care and long-term management of a blood cancer.

Side Effects

The side effects of treatment for essential thrombocythemia (ET) will depend on many factors, including the type of treatment and dosage, the age of the patient and coexisting medical conditions.

Management of side effects is important. Patients should discuss any concerns about side effects with their doctor. Most side effects are temporary and resolve when treatment is completed

ALL Subtypes

Doctors classify acute lymphoblastic leukemia (ALL) into subtypes by using various tests. It's important to get an accurate diagnosis since your subtype plays a large part in deciding the type of treatment you'll receive. Depending on your ALL subtype, the doctor will determine